Company Overview of Cumbre, Inc.
Cumbre, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new classes of antibacterial and antifungal drugs. The company was formerly known as Tularik Texas Corporation and changed its name to Cumbre, Inc. in September 2001. Cumbre, Inc. was founded in 2001 and is based in Dallas, Texas. Cumbre, Inc. is a former subsidiary of Tularik Inc.
1502 Viceroy Drive
Dallas, TX 75235
Founded in 2001
Key Executives for Cumbre, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cumbre, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.